TalkMed reports 9.7% y-o-y increase in FY2023 earnings to $32.7 mil

Medical oncology and stem cell services provider TalkMed Group (SGX:5G3) has reported earnings of $32.7 million for the FY2023 ended Dec 31, 2023, up 9.7% from its earnings of $29.8 million in FY2022.

For 2HFY2023, earnings increased 4% y-o-y to $18.5 million.